wiki pageCreated: 2026-04-02T07:19:11By: crosslink-migrationQuality:
50%✓ SciDEXID: wiki-proteins-wipi4-protein
📖 Wiki Page
protein604 wordssynced 2026-04-02
WIPI4 Protein
Overview
WIPI4 (WD Repeat Domain, Phosphoinositide Interacting protein 4), also known as WDR45L, is a phosphoinositide-binding protein that plays a critical role in autophagy regulation and membrane trafficking. This protein belongs to the WIPI family of proteins, which are characterized by conserved WD repeat domains and their ability to recognize and bind phosphatidylinositol-3-phosphate (PI3P) on cellular membranes. WIPI4 is ubiquitously expressed across tissues, with particular abundance in neurons, making it especially relevant to neurodegenerative disease pathology. As a key component of the autophagy pathway, WIPI4 serves as a scaffold protein that facilitates the recruitment of autophagy machinery to nascent autophagosomes, particularly under conditions of cellular stress and metabolic demand.
Function and Biology
WIPI4 functions primarily as a PI3P-binding adapter protein that helps coordinate the early stages of autophagosome formation. The protein contains multiple WD40 repeats that form a characteristic seven-bladed β-propeller structure, enabling it to interact with various autophagy-related proteins and phosphoinositides. Upon activation of the autophagy pathway, WIPI4 is recruited to the phagophore—the nascent autophagosomal membrane—through its direct binding to PI3P, a phosphoinositide generated by the Class III phosphatidylinositol 3-kinase (PI3K) complex containing VPS34, VPS15, and Beclin-1.
...
WIPI4 Protein
Overview
WIPI4 (WD Repeat Domain, Phosphoinositide Interacting protein 4), also known as WDR45L, is a phosphoinositide-binding protein that plays a critical role in autophagy regulation and membrane trafficking. This protein belongs to the WIPI family of proteins, which are characterized by conserved WD repeat domains and their ability to recognize and bind phosphatidylinositol-3-phosphate (PI3P) on cellular membranes. WIPI4 is ubiquitously expressed across tissues, with particular abundance in neurons, making it especially relevant to neurodegenerative disease pathology. As a key component of the autophagy pathway, WIPI4 serves as a scaffold protein that facilitates the recruitment of autophagy machinery to nascent autophagosomes, particularly under conditions of cellular stress and metabolic demand.
Function and Biology
WIPI4 functions primarily as a PI3P-binding adapter protein that helps coordinate the early stages of autophagosome formation. The protein contains multiple WD40 repeats that form a characteristic seven-bladed β-propeller structure, enabling it to interact with various autophagy-related proteins and phosphoinositides. Upon activation of the autophagy pathway, WIPI4 is recruited to the phagophore—the nascent autophagosomal membrane—through its direct binding to PI3P, a phosphoinositide generated by the Class III phosphatidylinositol 3-kinase (PI3K) complex containing VPS34, VPS15, and Beclin-1.
Once localized to the phagophore, WIPI4 recruits the ATG12-ATG5-ATG16 complex, a key ubiquitin-like conjugation system essential for autophagosomal elongation and membrane biogenesis. The protein also interacts with ATG2 and other components of the autophagy machinery to facilitate lipid transfer and membrane expansion. WIPI4 dissociates from completed autophagosomes, allowing subsequent maturation steps and fusion with lysosomes. Beyond its canonical autophagy role, WIPI4 participates in selective autophagy pathways, including mitophagy (selective degradation of mitochondria) and aggrephagy (selective autophagy of protein aggregates), processes particularly relevant to neurodegeneration.
Role in Neurodegeneration
WIPI4 dysfunction has emerged as a critical factor in multiple neurodegenerative diseases characterized by protein accumulation and cellular homeostasis failure. In Parkinson's disease, impaired WIPI4-mediated autophagy compromises the clearance of α-synuclein aggregates, leading to their pathological accumulation in Lewy bodies. Similarly, in Alzheimer's disease, WIPI4 dysregulation contributes to inadequate clearance of both amyloid-β and phosphorylated tau, promoting their toxic aggregation and propagation.
In Huntington's disease, huntingtin protein aggregates overwhelm autophagy capacity, and WIPI4 levels or function can become rate-limiting for aggregate removal. Emerging evidence suggests WIPI4 dysfunction also contributes to ALS pathology through impaired autophagy of TDP-43 and FUS protein inclusions. The protein's central role in maintaining neuronal proteostasis makes it a critical link between autophagy deficiency and neurodegeneration.
Molecular Mechanisms
WIPI4 dysfunction in neurodegeneration operates through several molecular mechanisms. Altered WIPI4 expression levels—whether decreased or dysregulated—directly reduce autophagy flux, limiting the cell's capacity to degrade misfolded proteins. Post-translational modifications of WIPI4, including phosphorylation and ubiquitination, can impair its PI3P-binding capacity or its recruitment to autophagy sites.
Interaction with stress-response kinases such as AMPK (AMP-activated protein kinase) and mTOR affects WIPI4 activity through phosphorylation cascades. Additionally, neuroinflammatory cytokines and oxidative stress can alter WIPI4 expression and localization in neurons, further compromising autophagy efficiency. Age-related decline in WIPI4 function may explain increased protein aggregate burden in aging brains.
Clinical and Research Significance
WIPI4 represents a promising therapeutic target for neurodegenerative diseases. Strategies to enhance WIPI4 expression or activity—including small molecules promoting autophagy initiation and protein-based therapeutics—are being investigated. Understanding WIPI4 dysfunction in patient-derived neurons and animal models provides insights into disease mechanisms and potential intervention points.